Pullback Risk Rising for JAZZ at $239.83
Shares of Jazz Pharmaceuticals PLC (JAZZ) rose 0.18% to $239.83 on May 26.
Key indicators suggest a bullish bias:
Moving Averages
The stock holds above both the 9-day ($233.61) and 21-day ($223.59) EMAs, confirming the uptrend.
Momentum
RSI at 75.9 is in overbought territory, suggesting potential near-term exhaustion. MACD is bullish (10.70 vs signal 9.76).
Volatility
Bollinger Band width at 24.9% indicates normal volatility.
The bullish trend is intact, but overbought momentum readings suggest waiting for a pullback.
Key levels to watch: Support at $194.41, Resistance at $249.72.
